Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes

Abstract

The present study has highlighted differences in circulating short-chain fatty acids in different hypertensive phenotypes and a possible influence of drug number and class. Although further research is necessary, this may represent a novel therapeutic target, particularly in patients with resistant hypertension.